Oxiwear, Inc.
OxiWear is a pioneering company dedicated to providing continuous, medical-grade blood oxygen monitoring through innovative ear-wearable technology. Founded in 2019 and based in Arlington, VA, the company aims to empower individuals with chronic conditions and improve healthcare outcomes by offering accurate, real-time oxygen data that is accessible and easy to share. Their mission is to reduce patient vulnerability to hypoxic injury and enhance safety and quality of life for users worldwide.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Ear-wearable continuous pulse oximeter
A medical-grade ear-worn sensor system that continuously measures blood oxygen saturation (SpO2) and pulse rate with second-by-second resolution, provides local haptic alerts and remote notifications, streams data to a mobile application, and supports data export for clinical use and research.
Ear-wearable continuous pulse oximeter
A medical-grade ear-worn sensor system that continuously measures blood oxygen saturation (SpO2) and pulse rate with second-by-second resolution, provides local haptic alerts and remote notifications, streams data to a mobile application, and supports data export for clinical use and research.
Services
Managed services covering device replacement, unlimited software and hardware updates, concierge onboarding and training, and on-demand technical support to support clinical and consumer deployments.
Managed services covering device replacement, unlimited software and hardware updates, concierge onboarding and training, and on-demand technical support to support clinical and consumer deployments.
Expertise Areas
- Continuous oxygen monitoring
- Wearable medical device design
- Clinical validation across skin tones
- Remote patient monitoring (RPM) integration
Key Technologies
- Ear-worn pulse oximetry
- Continuous SpO2 and pulse-rate monitoring
- Wireless wearable data transmission
- Mobile application with real-time visualization
News & Updates
The Pulmonary Hypertension Association (PHA) International Conference brought together a community of more than 1,000 attendees, including those living with PH and members of their care teams, from June 9-12, 2022.
OxiWear marked its fourth year since inception, highlighting its journey from a startup to a trusted provider of innovative oxygen monitoring solutions.
The company launched a new consumer website accepting pre-sale orders for its wireless, ear-wearable continuous oxygen tracking device at oxiwear.fitness.
Medical device network reports on OxiWear’s FDA clearance for its innovative blood oxygen monitoring device.
Washingtonian features a story about the inventor and CEO of OxiWear, highlighting its life-saving potential.
Sports Business Journal discusses how OxiWear’s ear-worn oximeter helps reduce hypoxic episodes.
The Pulmonary Hypertension Association (PHA) International Conference brought together a community of more than 1,000 attendees, including those living with PH and members of their care teams, from June 9-12, 2022.
OxiWear marked its fourth year since inception, highlighting its journey from a startup to a trusted provider of innovative oxygen monitoring solutions.
The company launched a new consumer website accepting pre-sale orders for its wireless, ear-wearable continuous oxygen tracking device at oxiwear.fitness.
Medical device network reports on OxiWear’s FDA clearance for its innovative blood oxygen monitoring device.
Washingtonian features a story about the inventor and CEO of OxiWear, highlighting its life-saving potential.
Sports Business Journal discusses how OxiWear’s ear-worn oximeter helps reduce hypoxic episodes.